On ECHEMI
Home > Drugs > Trifluoperazine hydrochloride

Trifluoperazine hydrochloride

Function and Efficacy

This product is a phenothiazine antipsychotic. Its antipsychotic effect is related to its blocking of dopamine receptors in the brain, inhibiting dopamine receptors in the emetic chemoreceptor area of the medulla oblongata and directly inhibiting the vomiting center, producing a strong antiemetic effect, but weak sedative and anticholinergic effects.

Ingredients

10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-phenothiazine dihydrochloride.

Appearance

This product is a sugar-coated tablet, which appears white after removing the sugar coating.

Indication

It is used for various types of schizophrenia, has an invigorating and activating effect, and is suitable for the catatonic stupor symptoms and the emotional indifference and behavioral withdrawal symptoms of simple and chronic schizophrenia.

Adverse Reactions

Extrapyramidal reactions are common, such as akathisia, acute dystonia and Parkinson's disease. Long-term and excessive use may cause tardive dyskinesia. Palpitations, insomnia, fatigue, dry mouth, blurred vision, dysuria, constipation, galactorrhea, gynecomastia, menstrual disorders, amenorrhea, etc. may occur. Rarely, drowsiness, restlessness, dizziness, and urinary retention are seen. Allergic rash, leukopenia and malignant syndrome are occasionally seen. Occasionally, it may cause postural hypotension, palpitations or electrocardiogram changes, elevated liver enzyme levels or obstructive jaundice, and epilepsy.

Precautions

Patients with basal ganglia lesions, Parkinson's disease, Parkinson's syndrome, bone marrow suppression, glaucoma, coma and allergy to phenothiazines.

Drug Interactions

1. When used in combination with ethanol or other central nervous system depressants, it can enhance the central inhibitory effect. 2. When used in combination with antihypertensive drugs, it can easily cause postural hypotension. 3. When used in combination with sultopride, this product increases the risk of ventricular arrhythmia, and in severe cases, it can cause torsades de pointes arrhythmia. 4. When used in combination with other atropine drugs, adverse reactions are additive.

Storage

Keep away from light and store in sealed container.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.